Searched for
GLAXOSMITHKLINE BIOLOGICALS
Samsung Biologics unveils $897 mln manufacturing deals for PfizerSouth Korea's Samsung Biologics announced on Tuesday two deals with Pfizer worth a combined $897 million to manufacture products for the U....04 Jul, 2023, 12.37 PM IST- CCI approves BC Asia Investments' stake acquisition in IIFL Wealth ManagementBC Asia Investments X Ltd is indirectly held by Bain Capital Investors LLC (Bain Private Equity), Bain Capital Credit Member LLC and Bain C...14 Jun, 2022, 09.21 PM IST
- Cipla, Kemwell Biopharma join hands to develop biosimilarsUnder the terms of the agreement, the joint venture will leverage Cipla and Kemwell’s complementary strengths for end-to-end product develo...25 Aug, 2021, 03.54 PM IST
- GSK to fund doctoral programs at Regional Centre for BiotechnologyStudents with a master’s degree in biostatistics, maths, statistics and bioinformatics can apply, and will have to take an aptitude test an...26 Jun, 2019, 07.02 PM IST
- Suresh Subramanian to head Biocon's branded formulations bizSuresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline,...19 Sep, 2016, 12.38 PM IST
- Rx: Make All Clinical Trial Data PublicShould drug companies make clinical trials data public?02 Apr, 2013, 08.24 AM IST
- GSK in 50:50 JV with Biological E for developing paediatric vaccineThe vaccine would enable fewer injections for children thereby improving compliance in immunisation schedules.29 Jan, 2013, 01.34 AM IST
- Four growth drivers beyond patent for pharma companies like Sun Pharma, SanofiIt is not just Big Pharma that has to prepare for life after the 'patent cliff'' patent expiries on a slew of blockbuster drugs.13 Oct, 2011, 08.46 AM IST
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.21 Apr, 2011, 01.53 AM IST
- DRL seeks USFDA help to make cancer drug cloneUS-based biotech firm Celgene, the innovator, has declined to make the drug samples available to DRL for bio-equivalence studies.31 Aug, 2009, 01.30 AM IST
- Pharma MNCs want to take a shot at India’s vaccine marketMultinational pharmaceutical companies are now increasingly looking at the Indian vaccine market in a big way. MSD Pharmaceuticals, GlaxoSm...12 Mar, 2009, 01.28 AM IST
- Cellworks' tech to eliminate testing of drugs on humansIn Cellworks' model, the effect of a drug on the specific disease can be seen exactly as it would happen in a human body, thereby eliminati...24 Mar, 2008, 05.09 AM IST
- GlaxoSmithKline wins European nod for bird flu vaccinesBritish pharmaceuticals giant GlaxoSmithKline has won European recommendations for two vaccines aimed at combatting a potential bird flu pa...22 Feb, 2008, 09.58 PM IST
- Diabetes drug may increase chances of osteoporosisThe popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an inc...04 Dec, 2007, 05.07 AM IST
- Zenotech likely to make a pref allotment to RanbaxyZenotech Laboratories will make a preferential allotment of its shares to Ranbaxy Laboratories. In a notice to the BSE, the company said th...11 Jul, 2006, 02.39 AM IST
- Ranbaxy to buy 10% in Zenotech for Rs 20 crRanbaxy Laboratories, is close to picking up a 10% stake in Hyderabad-based Zenotech Laboratories for about Rs 20 crore as it moves to plug...22 Jun, 2006, 12.39 AM IST
- LVPs can be produced under loan licenceThe government has cleared a proposal to allow manufacture of large volume parenterals under loan licences.25 Jul, 2002, 04.25 AM IST
Load More
